Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | October 09, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7TJ8 | Q9NY72 | Cryo-EM structure of the human Nax channel in complex with beta3 solved in nanodiscs | |
| 7TJ9 | Q01118 | Cryo-EM structure of the human Nax channel in complex with beta3 solved in GDN | |
| 7TJ9 | Q9NY72 | Cryo-EM structure of the human Nax channel in complex with beta3 solved in GDN | |
| 7TJO | 7TJO | HIV-1 gp120 complex with CJF-II-197-S | |
| 7TJP | 7TJP | HIV-1 gp120 complex with CJF-II-195 | |
| 7TJQ | 7TJQ | SAN27-14 bound to a antigenic site V on prefusion-stabilized hMPV F | |
| 7TJQ | H6X1Z0 | SAN27-14 bound to a antigenic site V on prefusion-stabilized hMPV F | |
| 7TKZ | P47929 | Crystal structure of D94A human Galectin-7 mutant in presence of lactose | |
| 7TL0 | H6X1Z0 | Cryo-EM structure of hMPV preF bound by Fabs MPE8 and SAN32-2 | |
| 7TL0 | 7TL0 | Cryo-EM structure of hMPV preF bound by Fabs MPE8 and SAN32-2 | |
| 7TL1 | P0DTC2 | SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron) | |
| 7TL9 | P0DTC2 | SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron) | |
| 7TLY | 7TLY | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) | |
| 7TLY | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) | |
| 7TLZ | 7TLZ | SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement | |
| 7TLZ | P0DTC2 | SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement | |
| 7TM0 | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
| 7TM0 | 7TM0 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
| 7TMC | Q9NUM4 | TMEM106B singlet filament extracted from MSTD neurodegenerative human brain | |
| 7TMZ | P08514 | Integrin alaphIIBbeta3 complex with BMS compound 4 | |
| 7TMZ | P05106 | Integrin alaphIIBbeta3 complex with BMS compound 4 | |
| 7TMZ | 7TMZ | Integrin alaphIIBbeta3 complex with BMS compound 4 | |
| 7TN0 | 7TN0 | SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 7TN0 | Q9BYF1 | SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 7TN0 | P0DTC2 | SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 7TN1 | W8RJF9 | Multistate design to stabilize viral class I fusion proteins | |
| 7TN9 | 7TN9 | Structure of the Inmazeb cocktail and resistance to escape against Ebola virus | |
| 7TN9 | Q05320 | Structure of the Inmazeb cocktail and resistance to escape against Ebola virus | |
| 7TNW | P0DTC2 | Structural and functional impact by SARS-CoV-2 Omicron spike mutations | |
| 7TO4 | P0DTC2 | Structural and functional impact by SARS-CoV-2 Omicron spike mutations | |
| 7TOH | A0A5M4AV20 | Crystal structure of carbohydrate esterase PbeAcXE, in complex with MeGlcpA-Xylp | |
| 7TOU | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; consensus state D1 | |
| 7TOV | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; consensus state D2 | |
| 7TOX | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D5 state | |
| 7TOY | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state | |
| 7TOZ | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D7 state | |
| 7TP0 | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D8 state | |
| 7TP1 | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D9 state | |
| 7TP2 | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state | |
| 7TP4 | 7TP4 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22 | |
| 7TP4 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22 | |
| 7TP7 | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D11 state | |
| 7TP8 | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D12 state | |
| 7TP9 | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D13 state | |
| 7TPA | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D14 state | |
| 7TPC | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D15 state | |
| 7TPD | P08514 | Integrin alaphIIBbeta3 complex with EF5154 | |
| 7TPD | P05106 | Integrin alaphIIBbeta3 complex with EF5154 | |
| 7TPD | 7TPD | Integrin alaphIIBbeta3 complex with EF5154 | |
| 7TPE | P0DTC2 | Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D16 state |
